Marrowstim
Device
Zimmer Biomet Holdings, Inc.
Total Payments
$2.3M
Transactions
524
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $27,654 | 7 | 0 |
| 2020 | $115,429 | 68 | 0 |
| 2019 | $202,352 | 80 | 0 |
| 2018 | $730,150 | 116 | 0 |
| 2017 | $1.2M | 253 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 473 | 97.5% |
| Consulting Fee | $53,250 | 14 | 2.3% |
| Travel and Lodging | $2,871 | 14 | 0.1% |
| Food and Beverage | $1,407 | 23 | 0.1% |
Payments by Type
Research
$2.3M
473 transactions
General
$57,527
51 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MarrowStim PAD Kit - Continued Access Study | Zimmer Biomet Holdings, Inc. | $1.3M | 0 |
| MarrowStim PAD Kit Study | Zimmer Biomet Holdings, Inc. | $418,783 | 1 |
| MarrowChamp Clinical and Histological Analysis | Zimmer Biomet Holdings, Inc. | $221,500 | 0 |
| MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Patients with Severe Peripheral Arterial Disease (PAD)(MOBILE) | Zimmer Biomet Holdings, Inc. | $57,483 | 0 |
| MarrowStim Blood Oxygen Level Determination MRI IDE Study | Zimmer Biomet Holdings, Inc. | $53,179 | 0 |
| MarrOwStim PAD Kit for the Treatment of Critical LimB IschemIa CLI in Subjects with Severe Peripheral ArteriaL DiseasE PAD MOBILE Continued Access | Zimmer Biomet Holdings, Inc. | $47,484 | 0 |
| MarrOwStim PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects with Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) | Zimmer Biomet Holdings, Inc. | $45,172 | 0 |
| MarrOwStim PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects with Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) Continued Access | Zimmer Biomet Holdings, Inc. | $40,427 | 0 |
| MarrOwStim PAD Kit for the Treatment of Critical LimB IschemIa CLI in Subjects with Severe Peripheral ArteriaL DiseasE PAD MOBILE | Zimmer Biomet Holdings, Inc. | $35,382 | 0 |
| MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia CLI in Patients with Severe Peripheral Arterial Disease PADMOBILE | Zimmer Biomet Holdings, Inc. | $9,225 | 0 |
| MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia CLI in Subjects with Severe Peripheral Arterial Disease PAD MOBILE - Continued Access | Zimmer Biomet Holdings, Inc. | $6,240 | 0 |
| MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia CLI in Subjects with Severe Peripheral Arterial Disease PAD | Zimmer Biomet Holdings, Inc. | $3,120 | 0 |
| MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia CLI in Subjects with Advanced Peripheral Arterial Disease PAD | Zimmer Biomet Holdings, Inc. | $1,560 | 0 |
| WIRB | Zimmer Biomet Holdings, Inc. | $794.00 | 0 |
Top Doctors Receiving Payments for Marrowstim
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $2.3M | 472 |
| , M.D | Interventional Cardiology | Effingham, IL | $25,356 | 17 |
| , M.D | Vascular & Interventional Radiology | Orange, CA | $10,078 | 10 |
| , MD | Cardiovascular Disease | Sacramento, CA | $8,535 | 9 |
| , MD | Vascular & Interventional Radiology | Saint Louis, MO | $7,242 | 6 |
| , MD | Vascular Surgery | Virginia Beach, VA | $6,317 | 9 |
| , MD | Cardiovascular Disease | Akron, OH | $82.50 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $2.3M
- Total Doctors 6
- Transactions 524
About Marrowstim
Marrowstim is a device associated with $2.3M in payments to 6 healthcare providers, recorded across 524 transactions in the CMS Open Payments database. The primary manufacturer is Zimmer Biomet Holdings, Inc..
Payment data is available from 2017 to 2021. In 2021, $27,654 was paid across 7 transactions to 0 doctors.
The most common payment nature for Marrowstim is "Unspecified" ($2.3M, 97.5% of total).
Marrowstim is associated with 14 research studies, including "MarrowStim PAD Kit - Continued Access Study" ($1.3M).